Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

In a scene that perfectly captures the strangeness of American politics today, President Trump, a billionaire and self-styled champion of American business (at least the ones he likes) was all smiles ...

A 1966 example of the Ford GT40 MkII is heading to auction in January—and it’s not just any example of the already ultra-rare car, but the “most original” one. Eleven MkII GT40s were built, and just ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

A new North Carolina traffic law impacts who is allowed to use the left lane. The short answer: unless you’re driving a massive commercial vehicle, this law probably doesn’t apply to you. The rule ...

Lane Kiffin changed the landscape of the SEC on Sunday. After six seasons in Oxford, Miss., Kiffin announced on Sunday that he is leaving Ole Miss to become the new head coach at LSU. Kiffin posted on ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Last night’s CNN clown show starring Alexandria Ocasio-Cortez and Crazy Bernie Sanders was nothing more than a desperate smokescreen to hide the brutal reality of the Democrat Shutdown. Make no ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...